Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JIANSHENG ZHAO

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1962591750
CMS profile
271110
Location
FLUSHING, NY

General Payments · PY2018–2024

$6,059.89

  • Reported across 212 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$931.61

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $920.05 32
Education $11.56 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $278.99 6
Acerta Pharma LLC $198.91 12
Phathom Pharmaceuticals, Inc. $194.89 3
Novo Nordisk AS $101.80 4
GlaxoSmithKline, LLC. $72.12 4
ABBVIE INC. $48.60 2
Exact Sciences Corporation $36.30 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,351.18 44
PY2019 $1,138.66 36
PY2020 $287.14 13
PY2021 $1,498.70 40
PY2022 $504.61 27
PY2023 $347.99 19
PY2024 $931.61 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $27.12 06/20/2024 Food and Beverage Undisputed 01/23/2026 1106395583 CMS
ABBVIE INC. $21.48 11/21/2024 Food and Beverage Undisputed 01/23/2026 1106395585 CMS
AstraZeneca Pharmaceuticals LP $15.07 03/01/2024 Food and Beverage Undisputed 01/23/2026 1105855100 CMS
AstraZeneca Pharmaceuticals LP $16.43 04/19/2024 Food and Beverage Undisputed 01/23/2026 1104731773 CMS
AstraZeneca Pharmaceuticals LP $11.56 04/19/2024 Education Undisputed 01/23/2026 1105628674 CMS
AstraZeneca Pharmaceuticals LP $17.11 06/14/2024 Food and Beverage Undisputed 01/23/2026 1104433509 CMS
AstraZeneca Pharmaceuticals LP $20.00 06/28/2024 Food and Beverage Undisputed 01/23/2026 1104659173 CMS
AstraZeneca Pharmaceuticals LP $11.07 06/28/2024 Food and Beverage Undisputed 01/23/2026 1104764774 CMS
AstraZeneca Pharmaceuticals LP $17.11 08/08/2024 Food and Beverage Undisputed 01/23/2026 1104258467 CMS
AstraZeneca Pharmaceuticals LP $14.70 08/15/2024 Food and Beverage Undisputed 01/23/2026 1105748851 CMS
AstraZeneca Pharmaceuticals LP $21.43 09/20/2024 Food and Beverage Undisputed 01/23/2026 1104744743 CMS
AstraZeneca Pharmaceuticals LP $18.38 11/01/2024 Food and Beverage Undisputed 01/23/2026 1105415241 CMS
AstraZeneca Pharmaceuticals LP $17.79 11/14/2024 Food and Beverage Undisputed 01/23/2026 1104517248 CMS
AstraZeneca Pharmaceuticals LP $18.26 12/05/2024 Food and Beverage Undisputed 01/23/2026 1104556750 CMS
Exact Sciences Corporation $16.33 02/23/2024 Food and Beverage Undisputed 01/23/2026 1114958783 CMS
Exact Sciences Corporation $19.97 06/07/2024 Food and Beverage Undisputed 01/23/2026 1114958786 CMS
Gilead Sciences, Inc. $25.19 03/29/2024 Food and Beverage Undisputed 01/23/2026 1133754698 CMS
Gilead Sciences, Inc. $19.24 05/20/2024 Food and Beverage Undisputed 01/23/2026 1133754700 CMS
Gilead Sciences, Inc. $150.00 06/11/2024 Food and Beverage Undisputed 01/23/2026 1133754702 CMS
Gilead Sciences, Inc. $25.75 10/01/2024 Food and Beverage Undisputed 01/23/2026 1133754704 CMS
Gilead Sciences, Inc. $30.68 10/18/2024 Food and Beverage Undisputed 01/23/2026 1133754706 CMS
Gilead Sciences, Inc. $28.13 11/22/2024 Food and Beverage Undisputed 01/23/2026 1133754708 CMS
GlaxoSmithKline, LLC. $17.31 03/21/2024 Food and Beverage Undisputed 01/23/2026 1116448592 CMS
GlaxoSmithKline, LLC. $20.37 05/24/2024 Food and Beverage Undisputed 01/23/2026 1116342168 CMS
GlaxoSmithKline, LLC. $15.97 08/29/2024 Food and Beverage Undisputed 01/23/2026 1116553089 CMS
GlaxoSmithKline, LLC. $18.47 12/06/2024 Food and Beverage Undisputed 01/23/2026 1115815237 CMS
Novo Nordisk Inc $24.07 05/17/2024 Food and Beverage Undisputed 01/23/2026 1097517908 CMS
Novo Nordisk Inc $24.39 07/29/2024 Food and Beverage Undisputed 01/23/2026 1097746633 CMS
Novo Nordisk Inc $23.12 10/16/2024 Food and Beverage Undisputed 01/23/2026 1096627096 CMS
Novo Nordisk Inc $30.22 12/20/2024 Food and Beverage Undisputed 01/23/2026 1097119001 CMS
Phathom Pharmaceuticals, Inc. $27.84 05/31/2024 Food and Beverage Undisputed 01/23/2026 1151142913 CMS
Phathom Pharmaceuticals, Inc. $141.51 06/27/2024 Food and Beverage Undisputed 01/23/2026 1151142915 CMS
Phathom Pharmaceuticals, Inc. $25.54 06/27/2024 Food and Beverage Undisputed 01/23/2026 1151142917 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.